Veterinary Medicine Information website

DEXAMETHASONE VMD 2 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS, GOATS, HORSES, DOGS AND CATS

Authorised
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
DEXAMETHASONE VMD 2 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS, GOATS, HORSES, DOGS AND CATS
Active substance:
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Pig
  • Cat
  • Equid
  • Goat
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Periarticular use
  • Intravenous use
  • Intraarticular use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        3
        day
    • Pig
      • Meat and offal
        2
        day
    • Equid
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        3
        day
  • Periarticular use
    • Equid
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        3
        day
    • Pig
      • Meat and offal
        6
        day
    • Equid
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        3
        day
  • Intraarticular use
    • Equid
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:
  • Box of 1 vial of 25 mL
  • Box of 1 vial of 50 mL
  • Box of 1 vial of 100 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
  • Laboratoires Biove
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 250148
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0505/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 10/11/2025
Download